Found: 7
Select item for more details and to access through your institution.
Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 5, p. 1, doi. 10.15252/emmm.202317580
- By:
- Publication type:
- Article
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1546, doi. 10.3390/vaccines11101546
- By:
- Publication type:
- Article
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1178, doi. 10.3390/vaccines10081178
- By:
- Publication type:
- Article
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 5, p. 1132, doi. 10.1002/1878-0261.13115
- By:
- Publication type:
- Article
Group 1 ILCs regulate T cell–mediated liver immunopathology by controlling local IL-2 availability.
- Published in:
- Science Immunology, 2022, v. 7, n. 68, p. 1, doi. 10.1126/sciimmunol.abi6112
- By:
- Publication type:
- Article
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion.
- Published in:
- Science Immunology, 2022, v. 7, n. 67, p. 1, doi. 10.1126/sciimmunol.abl9929
- By:
- Publication type:
- Article
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 426, p. 1, doi. 10.1126/scitranslmed.aan8723
- By:
- Publication type:
- Article